Breast cancer genetics: new insights

Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights.

Targeted therapy for neuroendocrine tumors

Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.

Research network yields significant findings related to obesity

Tennessee Advanced Communications Network expands to include state hospital systems

Vanderbilt University Medical Center to be an early adopter as a hospital system integrating the Tennessee Advanced Communications Network into its existing network of emergency providers for redundancy communications in the event of a disaster.

Patient undergoes novel therapy to treat pancreatic cancer

Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.

Tindle authors NCI guidance on treatment of cancer patients who smoke

Vanderbilt’s Hilary Tindle, MD, MPH, was one of the key contributors to the new Tobacco Control Monograph from the National Cancer Institute.